Detalles de la búsqueda
1.
Secondary vs. primary pituitary xanthogranulomas: which yellow is more mellow?
Endocr J
; 71(3): 285-293, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281757
2.
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.
Am J Hematol
; 96(9): 1156-1165, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161616
3.
Hypopituitarism in five PROP1 mutation siblings: long-lasting natural course and the effects of growth hormone replacement introduction in middle adulthood.
Pituitary
; 23(4): 400-408, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32415500
4.
Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease.
Blood Cells Mol Dis
; 78: 14-21, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27499018
5.
Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naïve or previously treated with imiglucerase.
Blood Cells Mol Dis
; 68: 163-172, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27839981
6.
Single center study of 53 consecutive patients with pituitary stalk lesions.
Pituitary
; 21(6): 605-614, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30276501
7.
Combined Administration of Ghrelin and Corticotropin-Releasing Hormone in the Diagnosis of Cushing's Disease.
Neuroendocrinology
; 104(1): 33-39, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-26836811
8.
Outcomes after 18 months of eliglustat therapy in treatment-naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trial.
Am J Hematol
; 92(11): 1170-1176, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28762527
9.
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.
Am J Hematol
; 91(7): 661-5, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27102949
10.
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease.
Am J Hematol
; 91(7): 656-60, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27174694
11.
Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial.
JAMA
; 313(7): 695-706, 2015 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25688781
12.
A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase.
Blood Cells Mol Dis
; 53(4): 253-60, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24950666
13.
Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
Blood Cells Mol Dis
; 77: 101-102, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31029022
14.
Recurrent spontaneous abortions, Hashimoto thyroiditis and alopecia totalis: response to anticoagulation and intravenous immunoglobulin therapy.
Gynecol Endocrinol
; 30(2): 100-2, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24308767
15.
Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience.
Int J Surg Pathol
; 32(3): 470-477, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37438981
16.
Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
Blood Cells Mol Dis
; 71: 71-74, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29680197
17.
Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease.
Blood
; 118(22): 5767-73, 2011 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21900191
18.
The cognitive profile of type 1 Gaucher disease patients.
J Inherit Metab Dis
; 35(6): 1093-9, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22350617
19.
Parathyroid hormone and calcitonin response during the calcium infusion test in patients with primary hyperparathyroidism.
Hormones (Athens)
; 21(2): 261-270, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35102498
20.
Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.
Brain
; 133(10): 2909-19, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20693542